Ionis Pharmaceuticals (IONS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Ionis Pharmaceuticals (IONS)

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
4676	121	0	IONS

Emcee: Keith Fauci	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
3401	Wall Street hesitant about Isis' lung cancer drug Fri Mar 14, 8:43 PM ET	bob zagorin	-	3/15/2003
3400	Genetic Engineering News Reports Biofirms Devising Anti-Biowarfare Agents 11 Ma	bob zagorin	-	3/11/2003
3399	reposted from yahoo but good refernce points. Affinitak (Inhibitor of protein k	bob zagorin	-	3/6/2003
3398	So, if the "litmus test" results come in fairly positive this month, a	Jess Beltz	-	3/6/2003
3397	Cancer Drugs' Iffy Profit Prognosis By David Shook Hopes that a new class	SemiBull	-	3/5/2003
3396	also CNBC had a feature on cos. that might profit from war on terrorism etc. and	bob zagorin	-	3/5/2003
3395	Hybridon Receives Patent Sublicense Income From Isis Pharmaceuticals CAMBRIDG	bob zagorin	-	3/5/2003
3394	Isis lung cancer data a litmus test for antisense Tuesday March 4, 3:34 pm ET B	Mr. Sunshine	-	3/4/2003
3393	MJ, Thanks, I have never been into technical analysis much, other than "bu	Mr. Sunshine	-	2/28/2003
3392	Steve Some feedback---being a contrarian is one way to make and keep your money	MJ	-	2/28/2003
3391	MJ, thank you for the thoughtful response. <<Just color me cynical---thin	Mr. Sunshine	-	2/27/2003
3390	Last week I received a report from my broker on ISIS dated January 18th-Street E	MJ	-	2/27/2003
3389	Steve This article is typical of what I call "oh by the way" articles	MJ	-	2/27/2003
3388	The Cost Of Conflict Biotechs See Dollar Signs In War Robert Langreth, 02.27.0	Mr. Sunshine	-	2/27/2003
3387	why do you say that? isis was up pretty solid yesterday on good volume and it wa	bob zagorin	-	2/26/2003
3386	Getting the feeling that no news is bad news here. Anyone have an inkling of wh	The Band Leader	-	2/26/2003
3385	reiterated today ISIS Pharm ISIS Fulcrum Buy	bob zagorin	-	2/13/2003
3384	Reminder - Webcast Alert: Isis Conference Call CARLSBAD, Calif., Feb. 11 /PRNe	bob zagorin	-	2/11/2003
3383	Isis Pharmaceuticals Reports Financial Results and Highlights for the Year 2002	bob zagorin	-	2/11/2003
3382	CARLSBAD, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (	nigel bates	-	2/10/2003
3381	CARLSBAD, Calif., Feb 07, 2003 /PRNewswire-FirstCall via Comtex/ -- Isis Pharmac	bob zagorin	-	2/7/2003
3380	here's part of the reason DOW JONES NEWSWIRES WASHINGTON -- Citigroup Inc.	bob zagorin	-	2/5/2003
3379	reiterated today. ISIS Pharm ISIS Needham & Co Strong Buy $24	bob zagorin	-	2/3/2003
3378	Elan Announces Recovery Plan Update and Settlement of Pharma Marketing Lawsuit	bob zagorin	-	1/30/2003
3377	I sold some April 10 covered calls @ $1.00 this week. Hope I will not be under	Mr. Sunshine	-	1/23/2003

Go to reply# or date (mm/dd/yy):